{"id":12895,"date":"2023-07-12T16:54:28","date_gmt":"2023-07-12T20:54:28","guid":{"rendered":"https:\/\/afcomunicacion.com\/uncategorized\/fda-approves-a-new-alzheimers-drug\/"},"modified":"2023-07-12T16:54:28","modified_gmt":"2023-07-12T20:54:28","slug":"fda-approves-a-new-alzheimers-drug","status":"publish","type":"post","link":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/","title":{"rendered":"FDA approves a new Alzheimer&#8217;s drug"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li><em>An estimated 6.5 million Americans have Alzheimer&#8217;s; the FDA has approved a new drug for people in the early stage of the disease, Cleveland Clinic specialists explain.<\/em><\/li>\n<\/ul>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\"><strong>CLEVELAND &#8211;<\/strong> According to the Centers for <strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">Disease Control and Prevention (CDC)<\/mark><\/strong>, an estimated 6.5 million Americans have <strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">Alzheimer&#8217;s<\/mark><\/strong> disease, which has no cure.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/FDA-aprueba-nuevo-medicamento.jpg\" alt=\"\" class=\"wp-image-8213\" width=\"342\" height=\"225\" srcset=\"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/FDA-aprueba-nuevo-medicamento.jpg 745w, https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/FDA-aprueba-nuevo-medicamento-300x197.jpg 300w\" sizes=\"auto, (max-width: 342px) 100vw, 342px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\">However, researchers are hopeful about a new drug recently approved by the <strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">Food and Drug Administration (FDA) <\/mark><\/strong>for people with early-stage disease.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\">&#8220;When we say <strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">Alzheimer&#8217;s<\/mark><\/strong>, it is a broad spectrum, ranging from very early stages to very advanced dementia,&#8221; said <strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Dr. Babak Tousi, a geriatric neurologist at<\/mark><\/strong> <strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Cleveland Clinic.<\/mark> <\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\">&#8220;At the moment, there are no findings to support using this drug for people with moderate to advanced dementia. It is for people in the very early stages of the disease.&#8221;<\/p>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\">The drug, called <strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">Lecanemab<\/mark><\/strong>, is designed to reduce <strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">beta-amyloid plaque<\/mark><\/strong> in the brain. <strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">Beta-amyloid plaque<\/mark><\/strong> has been linked to <strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">Alzheimer&#8217;s<\/mark><\/strong> disease.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\"><strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Dr. Tousi <\/mark><\/strong><mark class=\"has-inline-color has-black-color\">explained that the drug does not treat the symptoms of the disease but helps slow its progression.<\/mark><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro.jpg\" alt=\"\" class=\"wp-image-8215\" width=\"324\" height=\"213\" srcset=\"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro.jpg 745w, https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro-300x197.jpg 300w\" sizes=\"auto, (max-width: 324px) 100vw, 324px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\">As for success rates, results from an 18-month clinical trial showed that participants who received the drug had a 27 per cent reduction in<strong><mark style=\"color:#0b5d8c\" class=\"has-inline-color\"> beta-amyloid plaque.<\/mark><mark style=\"color:#138c00\" class=\"has-inline-color\"> Dr. Tousi<\/mark> <\/strong>said that percentage may seem small, but he believes it is a good starting point.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\">&#8220;It looks like we have some treatment. We can affect the trajectory of the disease. It&#8217;s a small benefit, but it&#8217;s still a benefit,&#8221; he said. &#8220;We can slow it down, and I think it&#8217;s one of many to come in the future to target it, so that&#8217;s the biggest breakthrough for us.&#8221;<\/p>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\"><mark style=\"color:#0b5d8c\" class=\"has-inline-color\">Documented side effects of the drug included microbleeds and oedema, which is a build-up of fluid in brain tissue.<\/mark><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n\n<p class=\"wp-block-paragraph\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"47\" src=\"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2022\/03\/Cleveland_Clinic_logo_color-300x47.png\" alt=\"\"><\/p>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\"><strong>About Cleveland Clinic<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-justify has-black-color has-text-color wp-block-paragraph\"><strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Cleveland Clinic<\/mark><\/strong> is a nonprofit multispecialty academic medical centre that integrates clinical and hospital care with research and education. Located in <strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Cleveland<\/mark><\/strong>, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based on the principles of cooperation, compassion and innovation. <strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Cleveland Clinic<\/mark><\/strong> has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. &nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify has-black-color has-text-color wp-block-paragraph\"><em>U.S. News &amp; World Report<\/em> consistently names <strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Cleveland Clinic<\/mark><\/strong> as one of the nation&#8217;s best hospitals in its annual &#8220;America&#8217;s Best Hospitals&#8221; survey. Among <strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Cleveland Clinic&#8217;s<\/mark><\/strong> 72,500 employees worldwide are more than 5,050 salaried physicians and researchers, and 17,800 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. &nbsp;<strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Cleveland Clinic<\/mark><\/strong> is a 6,500-bed health system that includes a 173-acre main campus near downtown Cleveland, 21 hospitals, more than 220 outpatient facilities, and locations in northeast Ohio; southeast Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. <\/p>\n\n\n\n<p class=\"has-text-align-justify has-black-color has-text-color wp-block-paragraph\">In 2021, there were 10.2 million outpatient visits, 304,000 hospital admissions and observations, and 259,000 surgeries across <strong><mark style=\"color:#138c00\" class=\"has-inline-color\">Cleveland Clinic&#8217;s<\/mark><\/strong> health system. Patients came for treatment from every state and 185 countries. &nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify has-black-color has-text-color wp-block-paragraph\">Visit us at <mark style=\"color:#138c00\" class=\"has-inline-color\"><span style=\"text-decoration: underline\">clevelandclinic.org<\/span><\/mark>. Follow us at twitter.com\/<mark style=\"color:#138c00\" class=\"has-inline-color\"><span style=\"text-decoration: underline\">ClevelandClinic<\/span><\/mark>. News and resources available at<mark style=\"color:#138c00\" class=\"has-inline-color\"><span style=\"text-decoration: underline\"> newsroom.clevelandclinic.org<\/span><\/mark>.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color wp-block-paragraph\"><em>Find out more about <mark><a href=\"https:\/\/afcomunicacion.com\/nosotros\/\"><mark style=\"background-color:#ffffff;color:#0b5d8c\" class=\"has-inline-color\"><span style=\"text-decoration: underline\">AF Comunicaci\u00f3n Estrat\u00e9gica<\/span><\/mark><\/a><mark style=\"background-color:#ffffff\" class=\"has-inline-color\"><a href=\"https:\/\/afcomunicacion.com\/nosotros\/\"> <\/a>and&nbsp;<\/mark><a href=\"https:\/\/afcomunicacion.com\/nuestros-clientes\/\"><mark style=\"background-color:#ffffff;color:#0b5d8c\" class=\"has-inline-color\"><span style=\"text-decoration: underline\">its clients<\/span><\/mark><\/a><\/mark><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CLEVELAND &#8211; According to the Centers for Disease Control and Prevention (CDC), an estimated 6.5 million Americans have Alzheimer&#8217;s disease, which has no cure. However, researchers are hopeful about a new drug recently approved by the Food and Drug Administration (FDA) for people with early-stage disease. &#8220;When we say Alzheimer&#8217;s, it is a broad spectrum, [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":8215,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[485],"tags":[3111,3112,3113,3114,3115,3116],"class_list":["post-12895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en","tag-cdc-en","tag-fda-en","tag-administracion-de-alimentos-y-medicamentos-fda-en","tag-control-y-la-prevencion-de-enfermedades-cdc-2-en","tag-lecanemab-en","tag-placa-beta-amiloide-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.6 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA approves a new Alzheimer&#039;s drug<\/title>\n<meta name=\"description\" content=\"According to the Centers for Disease Control and Prevention (CDC), an estimated 6.5 million Americans have Alzheimer&#039;s disease, which has no cure.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves a new Alzheimer&#039;s drug\" \/>\n<meta property=\"og:description\" content=\"According to the Centers for Disease Control and Prevention (CDC), an estimated 6.5 million Americans have Alzheimer&#039;s disease, which has no cure.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"AF Comunicaci\u00f3n Estrat\u00e9gica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/afcomunicacionestrategica\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-12T20:54:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"745\" \/>\n\t<meta property=\"og:image:height\" content=\"490\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"AF Comunicaci\u00f3n Estrat\u00e9gica\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AFComunicacion\" \/>\n<meta name=\"twitter:site\" content=\"@AFComunicacion\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"AF Comunicaci\u00f3n Estrat\u00e9gica\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/\"},\"author\":{\"name\":\"AF Comunicaci\u00f3n Estrat\u00e9gica\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#\\\/schema\\\/person\\\/fe64955688913b2174ea1635745e7379\"},\"headline\":\"FDA approves a new Alzheimer&#8217;s drug\",\"datePublished\":\"2023-07-12T20:54:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/\"},\"wordCount\":523,\"publisher\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/afcomunicacion.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Cerebro.jpg\",\"keywords\":[\"(CDC)\",\"(FDA)\",\"Administraci\u00f3n de Alimentos y Medicamentos (FDA)\",\"Control y la Prevenci\u00f3n de Enfermedades (CDC)\",\"Lecanemab\",\"placa beta amiloide\"],\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/\",\"url\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/\",\"name\":\"FDA approves a new Alzheimer's drug\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/afcomunicacion.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Cerebro.jpg\",\"datePublished\":\"2023-07-12T20:54:28+00:00\",\"description\":\"According to the Centers for Disease Control and Prevention (CDC), an estimated 6.5 million Americans have Alzheimer's disease, which has no cure.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/#primaryimage\",\"url\":\"https:\\\/\\\/afcomunicacion.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Cerebro.jpg\",\"contentUrl\":\"https:\\\/\\\/afcomunicacion.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Cerebro.jpg\",\"width\":745,\"height\":490},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/blog-en\\\/fda-approves-a-new-alzheimers-drug\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves a new Alzheimer&#8217;s drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/\",\"name\":\"AF Comunicaci\u00f3n Estrat\u00e9gica\",\"description\":\"Agencia especializada en consultor\u00eda de Comunicaci\u00f3n Estrat\u00e9gica, Relaciones P\u00fablicas y Eventos Corporativos.\",\"publisher\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#organization\",\"name\":\"AF Comunicaci\u00f3n Estrat\u00e9gica\",\"url\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/afcomunicacion.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/AF-LOGO.png\",\"contentUrl\":\"https:\\\/\\\/afcomunicacion.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/AF-LOGO.png\",\"width\":2560,\"height\":1024,\"caption\":\"AF Comunicaci\u00f3n Estrat\u00e9gica\"},\"image\":{\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/afcomunicacionestrategica\",\"https:\\\/\\\/x.com\\\/AFComunicacion\",\"https:\\\/\\\/www.instagram.com\\\/afcomunicacion\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/afcomunicacion\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCb0JkclVAyd3M9SzeiiNJAg\"],\"description\":\"AF Comunicaci\u00f3n Estrat\u00e9gica is a public relations and strategic communication agency founded in Santo Domingo, Dominican Republic, in 2006. Specialising in corporate communication, reputation management, crisis management, media relations and corporate events, it offers strategic solutions to companies and organisations, combining local expertise with international reach.\",\"foundingDate\":\"2006\",\"telephone\":\"+1 809 473-4541\",\"email\":\"info@afcomunicacion.com\",\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"Calle Mustaf\u00e1 Kemal Ataturk 39, Suite 401, Edificio Centre One, Naco\",\"addressLocality\":\"Santo Domingo\",\"addressCountry\":\"DO\"},\"areaServed\":{\"@type\":\"Country\",\"name\":\"Dominican Republic\"},\"knowsAbout\":[\"Public relations\",\"Corporate communication\",\"Crisis management\",\"Reputation management\",\"Internal communication\",\"Media relations\",\"Corporate events\",\"Health communication\"],\"memberOf\":{\"@type\":\"Organization\",\"name\":\"Worldcom Public Relations Group\",\"url\":\"https:\\\/\\\/worldcomgroup.com\\\/\",\"sameAs\":\"https:\\\/\\\/worldcomgroup.com\\\/partners\\\/af-comunicacion-estrategica\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/#\\\/schema\\\/person\\\/fe64955688913b2174ea1635745e7379\",\"name\":\"AF Comunicaci\u00f3n Estrat\u00e9gica\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/85f2cc1a31c5a2575f1b79ad47644a448b6cdfff59769f0219f7f09f29871d9e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/85f2cc1a31c5a2575f1b79ad47644a448b6cdfff59769f0219f7f09f29871d9e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/85f2cc1a31c5a2575f1b79ad47644a448b6cdfff59769f0219f7f09f29871d9e?s=96&d=mm&r=g\",\"caption\":\"AF Comunicaci\u00f3n Estrat\u00e9gica\"},\"url\":\"https:\\\/\\\/afcomunicacion.com\\\/en\\\/author\\\/dgonzalez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA approves a new Alzheimer's drug","description":"According to the Centers for Disease Control and Prevention (CDC), an estimated 6.5 million Americans have Alzheimer's disease, which has no cure.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/","og_locale":"en_US","og_type":"article","og_title":"FDA approves a new Alzheimer's drug","og_description":"According to the Centers for Disease Control and Prevention (CDC), an estimated 6.5 million Americans have Alzheimer's disease, which has no cure.","og_url":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/","og_site_name":"AF Comunicaci\u00f3n Estrat\u00e9gica","article_publisher":"https:\/\/www.facebook.com\/afcomunicacionestrategica","article_published_time":"2023-07-12T20:54:28+00:00","og_image":[{"width":745,"height":490,"url":"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro.jpg","type":"image\/jpeg"}],"author":"AF Comunicaci\u00f3n Estrat\u00e9gica","twitter_card":"summary_large_image","twitter_creator":"@AFComunicacion","twitter_site":"@AFComunicacion","twitter_misc":{"Written by":"AF Comunicaci\u00f3n Estrat\u00e9gica","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/#article","isPartOf":{"@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/"},"author":{"name":"AF Comunicaci\u00f3n Estrat\u00e9gica","@id":"https:\/\/afcomunicacion.com\/en\/#\/schema\/person\/fe64955688913b2174ea1635745e7379"},"headline":"FDA approves a new Alzheimer&#8217;s drug","datePublished":"2023-07-12T20:54:28+00:00","mainEntityOfPage":{"@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/"},"wordCount":523,"publisher":{"@id":"https:\/\/afcomunicacion.com\/en\/#organization"},"image":{"@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro.jpg","keywords":["(CDC)","(FDA)","Administraci\u00f3n de Alimentos y Medicamentos (FDA)","Control y la Prevenci\u00f3n de Enfermedades (CDC)","Lecanemab","placa beta amiloide"],"articleSection":["Blog"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/","url":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/","name":"FDA approves a new Alzheimer's drug","isPartOf":{"@id":"https:\/\/afcomunicacion.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/#primaryimage"},"image":{"@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro.jpg","datePublished":"2023-07-12T20:54:28+00:00","description":"According to the Centers for Disease Control and Prevention (CDC), an estimated 6.5 million Americans have Alzheimer's disease, which has no cure.","breadcrumb":{"@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/#primaryimage","url":"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro.jpg","contentUrl":"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/07\/Cerebro.jpg","width":745,"height":490},{"@type":"BreadcrumbList","@id":"https:\/\/afcomunicacion.com\/en\/blog-en\/fda-approves-a-new-alzheimers-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/afcomunicacion.com\/en\/"},{"@type":"ListItem","position":2,"name":"FDA approves a new Alzheimer&#8217;s drug"}]},{"@type":"WebSite","@id":"https:\/\/afcomunicacion.com\/en\/#website","url":"https:\/\/afcomunicacion.com\/en\/","name":"AF Comunicaci\u00f3n Estrat\u00e9gica","description":"Agencia especializada en consultor\u00eda de Comunicaci\u00f3n Estrat\u00e9gica, Relaciones P\u00fablicas y Eventos Corporativos.","publisher":{"@id":"https:\/\/afcomunicacion.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/afcomunicacion.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/afcomunicacion.com\/en\/#organization","name":"AF Comunicaci\u00f3n Estrat\u00e9gica","url":"https:\/\/afcomunicacion.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/afcomunicacion.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/11\/AF-LOGO.png","contentUrl":"https:\/\/afcomunicacion.com\/wp-content\/uploads\/2023\/11\/AF-LOGO.png","width":2560,"height":1024,"caption":"AF Comunicaci\u00f3n Estrat\u00e9gica"},"image":{"@id":"https:\/\/afcomunicacion.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/afcomunicacionestrategica","https:\/\/x.com\/AFComunicacion","https:\/\/www.instagram.com\/afcomunicacion\/","https:\/\/www.linkedin.com\/company\/afcomunicacion\/","https:\/\/www.youtube.com\/channel\/UCb0JkclVAyd3M9SzeiiNJAg"],"description":"AF Comunicaci\u00f3n Estrat\u00e9gica is a public relations and strategic communication agency founded in Santo Domingo, Dominican Republic, in 2006. Specialising in corporate communication, reputation management, crisis management, media relations and corporate events, it offers strategic solutions to companies and organisations, combining local expertise with international reach.","foundingDate":"2006","telephone":"+1 809 473-4541","email":"info@afcomunicacion.com","address":{"@type":"PostalAddress","streetAddress":"Calle Mustaf\u00e1 Kemal Ataturk 39, Suite 401, Edificio Centre One, Naco","addressLocality":"Santo Domingo","addressCountry":"DO"},"areaServed":{"@type":"Country","name":"Dominican Republic"},"knowsAbout":["Public relations","Corporate communication","Crisis management","Reputation management","Internal communication","Media relations","Corporate events","Health communication"],"memberOf":{"@type":"Organization","name":"Worldcom Public Relations Group","url":"https:\/\/worldcomgroup.com\/","sameAs":"https:\/\/worldcomgroup.com\/partners\/af-comunicacion-estrategica\/"}},{"@type":"Person","@id":"https:\/\/afcomunicacion.com\/en\/#\/schema\/person\/fe64955688913b2174ea1635745e7379","name":"AF Comunicaci\u00f3n Estrat\u00e9gica","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/85f2cc1a31c5a2575f1b79ad47644a448b6cdfff59769f0219f7f09f29871d9e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/85f2cc1a31c5a2575f1b79ad47644a448b6cdfff59769f0219f7f09f29871d9e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/85f2cc1a31c5a2575f1b79ad47644a448b6cdfff59769f0219f7f09f29871d9e?s=96&d=mm&r=g","caption":"AF Comunicaci\u00f3n Estrat\u00e9gica"},"url":"https:\/\/afcomunicacion.com\/en\/author\/dgonzalez\/"}]}},"_links":{"self":[{"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/posts\/12895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/comments?post=12895"}],"version-history":[{"count":0,"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/posts\/12895\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/media\/8215"}],"wp:attachment":[{"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/media?parent=12895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/categories?post=12895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/afcomunicacion.com\/en\/wp-json\/wp\/v2\/tags?post=12895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}